Benafentrine dimaleate

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 528323

CAS#: 76166-55-7 (dimaleate),

Description: Benafentrine dimaleate is a phosphodiesterase (PDE) 3/4 inhibitors and platelet activating factor receptor (PAFR) antagonists potentially for the treatment asthma.


Chemical Structure

img
Benafentrine dimaleate
CAS# 76166-55-7 (dimaleate),

Theoretical Analysis

MedKoo Cat#: 528323
Name: Benafentrine dimaleate
CAS#: 76166-55-7 (dimaleate),
Chemical Formula: C31H35N3O11
Exact Mass: 0.00
Molecular Weight: 625.631
Elemental Analysis: C, 59.51; H, 5.64; N, 6.72; O, 28.13

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 76166-55-7 (dimaleate)   35135-01-4 (free base)    

Synonym: Benafentrine dimaleate; Benafentrine; AH 21-132; AH-21-132 AH21-132; AH 21132; AH-21132 AH21132;

IUPAC/Chemical Name: Acetamide, N-[4-(1,2,3,4,4a,10b-hexahydro-8,9-dimethoxy-2-methylbenzo[c][1,6]naphthyridin-6-yl)phenyl]-, cis-, (Z)-2-butenedioate (1:2)

InChi Key: BWJFLHODOYZAML-DNEAOJAHSA-N

InChi Code: InChI=1S/C23H27N3O3.2C4H4O4/c1-14(27)24-16-7-5-15(6-8-16)23-18-12-22(29-4)21(28-3)11-17(18)19-13-26(2)10-9-20(19)25-23;2*5-3(6)1-2-4(7)8/h5-8,11-12,19-20H,9-10,13H2,1-4H3,(H,24,27);2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-/t19-,20-;;/m1../s1

SMILES Code: CC(NC1=CC=C(C2=N[C@]3([H])CCN(C)C[C@]3([H])C4=CC(OC)=C(OC)C=C24)C=C1)=O.O=C(O)/C=C\C(O)=O.O=C(O)/C=C\C(O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 625.63 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Yoshimura T, Kurita C, Nagao T, Usami E, Nakao T, Watanabe S, Kobayashi J, Yamazaki F, Tanaka H, Nagai H. Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Gen Pharmacol. 1997 Oct;29(4):633-8. doi: 10.1016/s0306-3623(96)00580-0. PMID: 9352314.


2: Dietrich C, Kilbinger H. 5-HT1A receptor-mediated inhibition of acetylcholine release from guinea pig myenteric plexus: potential mechanisms. Neuropharmacology. 1996 Apr;35(4):483-8. doi: 10.1016/0028-3908(95)00197-2. PMID: 8793911.


3: Seldon PM, Barnes PJ, Meja K, Giembycz MA. Suppression of lipopolysaccharide- induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. Mol Pharmacol. 1995 Oct;48(4):747-57. PMID: 7476903.


4: Abrahamsen J, Nedergaard OA. Role of cyclic AMP in stimulation-evoked release of 3H-noradrenaline from rabbit isolated ear artery. Pharmacol Toxicol. 1995 Mar;76(3):185-9. doi: 10.1111/j.1600-0773.1995.tb00127.x. PMID: 7617543.


5: Nagai H, Takeda H, Iwama T, Yamaguchi S, Mori H. Studies on anti-allergic action of AH 21-132, a novel isozyme-selective phosphodiesterase inhibitor in airways. Jpn J Pharmacol. 1995 Feb;67(2):149-56. doi: 10.1254/jjp.67.149. PMID: 7542355.


6: Nagai H, Yamaguchi S, Kitagaki K, Tsuruoka N, Koda A. Priming with murine recombinant interleukin-5 resulted in the augmentation of PAF-induced airway hyperresponsiveness to histamine in guinea pigs. Life Sci. 1993;52(17):PL147-51. doi: 10.1016/0024-3205(93)90070-j. PMID: 8464339.


7: Foster RW, Rakshi K, Carpenter JR, Small RC. Trials of the bronchodilator activity of the isoenzyme-selective phosphodiesterase inhibitor AH 21-132 in healthy volunteers during a methacholine challenge test. Br J Clin Pharmacol. 1992 Dec;34(6):527-34. doi: 10.1111/j.1365-2125.1992.tb05658.x. PMID: 1493085; PMCID: PMC1381455.


8: Souness JE, Carter CM, Diocee BK, Hassall GA, Wood LJ, Turner NC. Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation. Biochem Pharmacol. 1991 Jul 25;42(4):937-45. doi: 10.1016/0006-2952(91)90056-b. PMID: 1651083.


9: Giembycz MA, Barnes PJ. Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachealis by AH 21-132. Relevance to the spasmolytic and anti-spasmogenic actions of AH 21-132 in the intact tissue. Biochem Pharmacol. 1991 Jul 15;42(3):663-77. doi: 10.1016/0006-2952(91)90330-8. PMID: 1650218.


10: Suganuma T, Imai T, Idaira K, Konno S, Hoshino H, Okazawa A, Adachi M, Takahashi T, Maeda M, Tsuji A. [The effect of AH 21-132 on airway hyperresponsiveness induced by ozone exposure]. Arerugi. 1991 May;40(5):529-37. Japanese. PMID: 1883268.


11: Small RC, Berry JL, Boyle JP, Chapman ID, Elliott KR, Foster RW, Watt AJ. Biochemical and electrical aspects of the tracheal relaxant action of AH 21-132. Eur J Pharmacol. 1991 Jan 17;192(3):417-26. doi: 10.1016/0014-2999(91)90234-h. PMID: 1647318.


12: Small RC, Foster RW, Berry JL, Chapman ID, Elliott KR. The bronchodilator action of AH 21-132. Agents Actions Suppl. 1991;34:3-26. PMID: 1665308.


13: Elliott KR, Berry JL, Bate AJ, Foster RW, Small RC. The isoenzyme selectivity of AH 21-132 as an inhibitor of cyclic nucleotide phosphodiesterase activity. J Enzyme Inhib. 1991;4(3):245-51. doi: 10.3109/14756369109035848. PMID: 1645399.


14: Sanjar S, Aoki S, Kristersson A, Smith D, Morley J. Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs. Br J Pharmacol. 1990 Apr;99(4):679-86. doi: 10.1111/j.1476-5381.1990.tb12989.x. PMID: 2361168; PMCID: PMC1917560.


15: Sanjar S, Aoki S, Boubekeur K, Chapman ID, Smith D, Kings MA, Morley J. Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs. Br J Pharmacol. 1990 Feb;99(2):267-72. doi: 10.1111/j.1476-5381.1990.tb14692.x. PMID: 2328394; PMCID: PMC1917376.


16: Kings MA, Chapman I, Kristersson A, Sanjar S, Morley J. Human recombinant lymphokines and cytokines induce pulmonary eosinophilia in the guinea pig which is inhibited by ketotifen and AH 21-132. Int Arch Allergy Appl Immunol. 1990;91(4):354-61. doi: 10.1159/000235141. PMID: 2210871.


17: Small RC, Boyle JP, Elliott KR, Foster RW, Watt AJ. Inhibitory effects of AH 21-132 in guinea-pig isolated ileum and taenia caeci. Br J Pharmacol. 1989 Aug;97(4):1174-81. doi: 10.1111/j.1476-5381.1989.tb12576.x. PMID: 2551443; PMCID: PMC1854628.


18: Small RC, Boyle JP, Duty S, Elliott KR, Foster RW, Watt AJ. Analysis of the relaxant effects of AH 21-132 in guinea-pig isolated trachealis. Br J Pharmacol. 1989 Aug;97(4):1165-73. doi: 10.1111/j.1476-5381.1989.tb12575.x. PMID: 2551442; PMCID: PMC1854606.


19: Racké K, Schwörer H, Kilbinger H. Adrenergic modulation of the release of 5-hydroxytryptamine from the vascularly perfused ileum of the guinea-pig. Br J Pharmacol. 1988 Nov;95(3):923-31. doi: 10.1111/j.1476-5381.1988.tb11722.x. PMID: 2463031; PMCID: PMC1854204.


20: Briggs CA, McAfee DA, McCaman RE. Long-term regulation of synaptic acetylcholine release and nicotinic transmission: the role of cyclic AMP. Br J Pharmacol. 1988 Feb;93(2):399-411. doi: 10.1111/j.1476-5381.1988.tb11447.x. PMID: 2833971; PMCID: PMC1853801.